Cottonwood Capital Advisors’s Pfizer PFE Stock Holding History

Cottonwood Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,596	Closed	-$205K	–	108
2023 Q2	$205K	Sell	5,596 -104	-2%	-$4.05K	0.19%	91
2023 Q1	$233K	Sell	5,700 -59	-1%	-$2.55K	0.21%	82
2022 Q4	$295K	Hold	5,759	–	–	0.26%	73
2022 Q3	$252K	Hold	5,759	–	–	0.24%	74
2022 Q2	$302K	Sell	5,759 -14	-0.2%	-$713	0.27%	67
2022 Q1	$299K	Sell	5,773 -278	-5%	-$14.4K	0.24%	71
2021 Q4	$357K	Buy	+6,051	New	+$300K	0.28%	68

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cottonwood Capital Advisors's PFE Position: Q3 2023 in Review

Cottonwood Capital Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,596 shares — an estimated $205K sold.

Cottonwood Capital Advisors first reported a position in PFE in Q4 2021 and held it in 7 quarters. The position peaked at $357K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Cottonwood Capital Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Cottonwood Capital Advisors sold 5,596 Pfizer shares in Q3 2023, an estimated $205K.
Cottonwood Capital Advisors first reported a position in Pfizer in Q4 2021 and held it in 7 quarters.
Cottonwood Capital Advisors's Pfizer position peaked at $357K in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Cottonwood Capital Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.